Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2025.
-
Busy address KBO
26 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Cryptobiotix from Gent, company number BE0762565104, closed financial year 2025 with a result of € 1.8 million after tax. For that financial year Cryptobiotix recorded a gross margin of € 3.9 million and equity of € 3.7 million. Compared with financial year 2024, the result moved from € 1.2 million to € 1.8 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 3.7 million
▲ 87% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.8 million
▲ 50% vs 2024
Profit after tax over the fiscal year.
€ 572,390
▼ 75% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 3.6 million.
People and assets in 2025
15.8
▲ 6.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.4 million
▲ 64% vs 2024
€ 88,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 78,236
▼ 40% vs 2024
Of which on lease € 44,208.
Debts at end 2025
€ 86,704
▼ 47% vs 2024
€ 51,230 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 239,119
▼ 43% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 260,905
▲ 100% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 883,722 | € 1,585,774 | € 2,473,910 | € 3,868,670 | ▲ 56% |
| Profit after taxes | € 501,562 | € 618,522 | € 1,178,089 | € 1,764,513 | ▲ 50% |
| Equity | € 593,067 | € 1,199,218 | € 1,979,857 | € 3,700,258 | ▲ 87% |
| Total debts | € 1,236,041 | € 1,516,624 | € 2,250,346 | € 1,999,923 | ▼ 11% |
| Cash | € 509,564 | € 1,505,959 | € 2,266,473 | € 572,390 | ▼ 75% |
| Retained profit | € 531,567 | € 1,137,718 | € 1,918,357 | € 3,638,758 | ▲ 90% |
| Dividend | € 100,000 | € 0 | € 368,000 | € 0 | ▼ 100% |
| Bank debt | € 214,370 | € 242,674 | € 164,092 | € 86,704 | ▼ 47% |
| Balance sheet total | € 1,829,107 | € 2,715,842 | € 4,230,203 | € 5,700,181 | ▲ 35% |
| Employees (FTE) | 2.6 | 8.3 | 9.4 | 15.8 | ▲ 6.4 |
Key figures of Cryptobiotix, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Cryptobiotix?
What happened at Cryptobiotix in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 1.8 million (▲ 50% vs 2024). Source: NBB ↗
- AB INITIO MANAGEMENT BV became a director. NBB
- PVDA BIOSCIENCES BV became a director. NBB
- Pieter Van den Abbeele stepped down as director. NBB
- Aurélien Baudot stepped down as director. NBB
- Pieter Van den Abbeele became a director. NBB
- Aurélien Baudot became a director. NBB
- New establishment in Gent. KBO
In short
From € 501,562 profit in 2022 to € 1.8 million profit in 2025.
Paid € 1.2 million in corporate taxes since 2022.
Best year ever: 2025, with € 1.8 million profit.
On average € 244,900 of value added per employee in 2025.
A new publication or filing at Cryptobiotix? We notify you, reason included.
Follow CryptobiotixDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Cryptobiotix are AB INITIO MANAGEMENT BV and PVDA BIOSCIENCES BV.
Directors
According to the 2025 annual accounts
Director · represented by Baudot Aurélien
since 2025
Director · represented by Van den Abbeele Pieter
since 2025
Pieter Van den Abbeele
Managing director
since 2021 · until 2025
Aurélien Baudot
Managing director
since 2021 · until 2025
Establishments
Establishment units
Physical locations of this company
Technologiepark-Zwijnaarde 82
9052 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 26 companies are registered at this address.
All companies at this address →CONTREL EUROPE
€ 250,724 gross margin · 2025
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT
€ 1.4 million gross margin · 2025
VP VENTURES
€ -1,670 gross margin · 2025
SENSNET
Inbiose
€ 6.3 million revenue · 2025
+21 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Domain
Domain
cryptobiotix.eu
Registrar
Combell NV
Website info
Features
Security
Details
- Company number
- 0762.565.104
- VAT number
- BE 0762.565.104
- Registered office
- Technologiepark-Zwijnaarde 82, 9052 Gent
- Names & denominations
- Cryptobiotix
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 January 2021
- Peppol
- Active · Active since 27 Mar 2026
- Contact
- cryptobiotix.eu [email protected]
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overige technische testen en toetsen